{"id":"W2986312172","doi":"10.25251/skin.3.supp.39","title":"Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled 96-Week Data from Three Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT)","year":2019,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"","keywords":"Certolizumab pegol; Placebo; Medicine; Psoriasis; Plaque psoriasis; Randomized controlled trial; Multicenter study; Internal medicine; Dermatology; Adalimumab; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001808312,0.0004714509,0.003121156,0.0003434007,0.0001191255,0.00001029613,0.0008491786,0.0002460972,0.0006445017],"category_scores_gemma":[0.002076497,0.0002435952,0.0002437741,0.000180764,0.000620013,0.0001843049,0.0002115417,0.0005283683,0.00003193659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001041937,"about_ca_system_score_gemma":0.000157261,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004686284,"about_ca_topic_score_gemma":0.0006016374,"domain_scores_codex":[0.9954609,0.001632383,0.001881662,0.0003335224,0.0002335488,0.0004580009],"domain_scores_gemma":[0.9894268,0.007847318,0.001584892,0.0008221078,0.0002379393,0.00008092752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9392323,0.000895613,0.001005668,0.00006927414,0.01024581,0.000698123,0.00732538,0.00003208776,0.01998694,0.00002647993,0.002262041,0.01822028],"study_design_scores_gemma":[0.9674029,0.002890077,0.000359471,0.001237989,0.006990627,0.007827056,0.008017326,0.0004169089,0.0030957,0.0006407458,0.0008034573,0.0003176959],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9210989,0.07171986,0.000115763,0.002983721,0.001982027,0.001664938,0.0002068642,0.00001482035,0.0002131393],"genre_scores_gemma":[0.9838032,0.01531866,0.00007346451,0.0001152302,0.0002628663,0.0000118332,0.00008919304,0.00003233581,0.0002931826],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06270436,"threshold_uncertainty_score":0.9933523,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02894658660659985,"score_gpt":0.2972223779139177,"score_spread":0.2682757913073179,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}